111 related articles for article (PubMed ID: 18992885)
1. Improved conjugation and purification strategies for the preparation of protein-polysaccharide conjugates.
Suárez N; Massaldi H; Franco Fraguas L; Ferreira F
J Chromatogr A; 2008 Dec; 1213(2):169-75. PubMed ID: 18992885
[TBL] [Abstract][Full Text] [Related]
2. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
3. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents.
Lees A; Nelson BL; Mond JJ
Vaccine; 1996 Feb; 14(3):190-8. PubMed ID: 8920699
[TBL] [Abstract][Full Text] [Related]
4. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
5. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Front Immunol; 2020; 11():578019. PubMed ID: 33343566
[TBL] [Abstract][Full Text] [Related]
6. Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate vaccine.
Farkas P; Korcová J; Kronek J; Bystrický S
Eur J Med Chem; 2010 Feb; 45(2):795-9. PubMed ID: 19939517
[TBL] [Abstract][Full Text] [Related]
7. Application of cystamine and N,N'-Bis(glycyl)cystamine as linkers in polysaccharide-protein conjugation.
de Weers O; Beurret M; van Buren L; Oomen LA; Poolman JT; Hoogerhout P
Bioconjug Chem; 1998; 9(3):309-15. PubMed ID: 9576804
[TBL] [Abstract][Full Text] [Related]
8. Development of approaches to creation of experimental test system for evaluation of antigenic activity of synthetic oligosaccharide ligands related to fragments of the Streptococcus pneumoniae type 14 capsular polysaccharide.
Kurbatova EA; Vorobiov DS; Semenova IB; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Biochemistry (Mosc); 2013 Jul; 78(7):818-22. PubMed ID: 24010843
[TBL] [Abstract][Full Text] [Related]
9. Purification of capsular polysaccharide from Streptococcus pneumoniae serotype 23F by a procedure suitable for scale-up.
Gonçalves VM; Takagi M; Lima RB; Massaldi H; Giordano RC; Tanizaki MM
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):283-7. PubMed ID: 12515577
[TBL] [Abstract][Full Text] [Related]
10. O-phthalaldehyde based quantification of polysaccharide modification in conjugate vaccines.
Rajendar B; Reddy MVNJ; Suresh CNV; Rao GS; Matur RV
J Pharm Biomed Anal; 2024 Apr; 241():115995. PubMed ID: 38309096
[TBL] [Abstract][Full Text] [Related]
11. A polysaccharide of Alloiococcus otitidis, a new pathogen of otitis media: chemical structure and synthesis of a neoglycoconjugate thereof.
Arar S; Vinogradov E; Shewmaker PL; Monteiro MA
Carbohydr Res; 2008 May; 343(6):1079-90. PubMed ID: 18336800
[TBL] [Abstract][Full Text] [Related]
12. TEMPO-mediated glycoconjugation: a scheme for the controlled synthesis of polysaccharide conjugates.
Ma Z; Bertolo L; Arar S; Monteiro MA
Carbohydr Res; 2011 Feb; 346(2):343-7. PubMed ID: 21167478
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
Verheul AF; Versteeg AA; De Reuver MJ; Jansze M; Snippe H
Infect Immun; 1989 Apr; 57(4):1078-83. PubMed ID: 2925240
[TBL] [Abstract][Full Text] [Related]
14. The human polysaccharide- and protein-specific immune response to Streptococcus pneumoniae is dependent on CD4(+) T lymphocytes, CD14(+) monocytes, and the CD40-CD40 ligand interaction.
Moens L; Wuyts G; Boon L; den Hartog MT; Ceuppens JL; Bossuyt X
J Allergy Clin Immunol; 2008 Dec; 122(6):1231-3. PubMed ID: 18842293
[No Abstract] [Full Text] [Related]
15. Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
Safari D; Marradi M; Chiodo F; Th Dekker HA; Shan Y; Adamo R; Oscarson S; Rijkers GT; Lahmann M; Kamerling JP; Penadés S; Snippe H
Nanomedicine (Lond); 2012 May; 7(5):651-62. PubMed ID: 22630149
[TBL] [Abstract][Full Text] [Related]
16. T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of
Middleton DR; Sun L; Paschall AV; Avci FY
J Immunol; 2017 Jul; 199(2):598-603. PubMed ID: 28566369
[TBL] [Abstract][Full Text] [Related]
17. [Capsular polysaccharide of Klebsiella pneumoniae. II. Immunogenic properties].
Alcántar-Curiel MD; Martínez-Ramos A; García-Latorre E
Rev Latinoam Microbiol; 1993; 35(1):109-15. PubMed ID: 8140330
[TBL] [Abstract][Full Text] [Related]
18. Production of capsular polysaccharide of Streptococcus pneumoniae type 14 and its purification by affinity chromatography.
Suárez N; Fraguas LF; Texeira E; Massaldi H; Batista-Viera F; Ferreira F
Appl Environ Microbiol; 2001 Feb; 67(2):969-71. PubMed ID: 11157270
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenic activity of a conjugate of synthetic hexasaccharide related to a streptococcus pneumoniae serotype 14 capsule polysaccharide chain fragment].
Kurbatova EA; Vorob'ev DS; Egorova NB; Semenova IB; Sukhova EV; Iashunskiĭ DV; Tsvetkov IuE; Nifant'ev NÉ
Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):56-63. PubMed ID: 24605676
[TBL] [Abstract][Full Text] [Related]
20. Efficient synthesis and protein conjugation of beta-(1-->6)-D-N-acetylglucosamine oligosaccharides from the polysaccharide intercellular adhesin.
Leung C; Chibba A; Gómez-Biagi RF; Nitz M
Carbohydr Res; 2009 Mar; 344(5):570-5. PubMed ID: 19185294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
